A recent report published by
Infinium Global Research on the cell and tissue preservation market provide an in-depth analysis of segments and sub-segments in the global as well as
regional cell and tissue preservation market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
cell and tissue preservation market over the short term as well as the long term.
The report is a comprehensive presentation of trends, forecast and dollar
values of the global cell and tissue preservation market. According to the report,
the global cell and tissue preservation market is projected to grow at a CAGR of over 12% over the forecast period of 2022-2028.
The global cell and tissue preservation market was valued at about USD 4.5 billion in 2022 and is expected to reach nearly USD 9 billion in 2028, with a CAGR of over 12% during the forecast period. Cell and tissue preservation defines the process of preserving cells, tissues, or organs outside of their native environment for an extended period of time. It is known as an effective preservation technique for long-duration storage. Due to this, cell and tissue preservation have become vital for the success of various clinical and commercial applications of evolving cell-based technologies. Furthermore, it is exclusively used for retaining the functionality and integrity of clinical trial material, embryos, sperms, eggs, etc. in various healthcare institutes. Preservation of cells permits the transportation of cells between sites, as well as the completion of safety and quality control testing. Preservation also allows the development of a producing paradigm for cell therapies, thereby reducing the number of products that can be manufactured at a given facility.
Technological advancements in bio-preservation processes are also major market growth factors. Advancements
include changes in the formulation of hypothermic storage solutions,
next-generation cryopreservation solutions, and design and integration with
Nanoscale technologies. These technological upgrades have led to the long-term
preservation and banking of complex organs and tissues of high importance in
regenerative medicine and organ transplantation. Increasing R&D investments
by companies and research communities to enhance their capabilities and render
efficient products and services is predicted to expand growth prospects
further. For instance, the establishment of the Cooperative Human Tissue
Network (CHTN), which addressed the operational dimension of bio-banking,
exemplifies consistent efforts by the research community. However, the high
cost of preservation will hamper the growth of the market in the forecast
period. The major restrain that occurred during the preservation is damage
caused due to ice formation, and dehydration before it gets frozen.
Based on region, the world cell
and tissue preservation market has been segregated into North America, Asia
Pacific, Europe, & Africa. North America market relatively records a surge
in revenue for the global cell and tissue preservation market in the forecast
period. Advanced technologies, the presence of accredited tissue banks, and
increased donation of tissues due to rising awareness of preventive care
measures are projected to drive the growth of the North American cell and
tissue preservation market to an extent level. Europe is the second-largest
cell and tissue preservation market and is expected to generate new prospects
in the forecast period. An increase in the cases of chronic diseases, and a
rising aged population in the European economy will boost the growth in the
region. The Asia Pacific is an emerging market for cell and tissue preservation
market and is anticipated to perform at a high growth rate during the forecast
period. Due to different new rising private competitors and research
initiatives taken by governments of developing countries will grow the market
in this region. India and China are the key countries contributing to the
growth of the Asia Pacific region. The cell and tissue preservation market in
India is anticipated to grow with a high presence of expertise in research.
The report on the global cell and
tissue preservation market covers segments such as type, application, and end
user. On the basis of type, the sub-markets include cell preservation, and
tissue preservation. On the basis of application, the sub-markets include
therapeutics, research & development, drug discovery, cell therapy, gene
therapy, and IVF treatments. On the basis of end user, the sub-markets include
biobanks, hospitals, and others.
The report provides profiles of
the companies in the market such as Thermo Fisher Scientific, Inc., LabVantage
Solutions, Inc., VWR Corporation, Biolife Solutions, Inc., Lifeline Scientific,
Inc., Cesca Therapeutics, Inc., BioCision, Core Dynamics, Ltd., Custom Biogenic
Systems, Inc., and Chart MVE Biomedical.
The report provides deep insights
into demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the cell and tissue preservation market. Moreover, the study highlights
current market trends and provides forecast from 2022-2028. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings insight into the market share of the leading players.